BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23161037)

  • 1. Current therapeutic strategy in Alzheimer's disease.
    Singh S; Kushwah AS; Singh R; Farswan M; Kaur R
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1651-64. PubMed ID: 23161037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying therapies in Alzheimer's disease.
    Salloway S; Mintzer J; Weiner MF; Cummings JL
    Alzheimers Dement; 2008 Mar; 4(2):65-79. PubMed ID: 18631951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel disease-modifying therapies for Alzheimer's disease.
    Jiang T; Yu JT; Tan L
    J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the development of new drugs in Alzheimer's disease.
    Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
    J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights for the treatment of Alzheimer's disease.
    Kurz A; Perneczky R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutics of Alzheimer's disease: Past, present and future.
    Anand R; Gill KD; Mahdi AA
    Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
    Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
    Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Alzheimer's disease.
    Solomon B; Frenkel D
    Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucagon-like peptide 1: a novel therapeutic strategy for Alzheimer's disease].
    Wang XH; Yang W; Qi JS
    Sheng Li Xue Bao; 2010 Oct; 62(5):398-406. PubMed ID: 20945041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs targeting Alzheimer's disease: some things old and some things new.
    Michaelis ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection.
    Caraci F; Spampinato S; Sortino MA; Bosco P; Battaglia G; Bruno V; Drago F; Nicoletti F; Copani A
    Cell Tissue Res; 2012 Jan; 347(1):291-301. PubMed ID: 21879289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
    Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Alzheimer's disease: current and future therapeutic approaches.
    Cummings JL
    Rev Neurol Dis; 2004; 1(2):60-9. PubMed ID: 16400259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
    Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
    Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.
    Bak AM; Egefjord L; Gejl M; Steffensen C; Stecher CW; Smidt K; Brock B; Rungby J
    Expert Opin Ther Targets; 2011 Oct; 15(10):1153-62. PubMed ID: 21749267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches in the treatment of Alzheimer's disease.
    Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
    Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.
    Rojo LE; Fernández JA; Maccioni AA; Jimenez JM; Maccioni RB
    Arch Med Res; 2008 Jan; 39(1):1-16. PubMed ID: 18067990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.